309 related articles for article (PubMed ID: 35413794)
1. Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study.
Jia Y; Li D; Yu J; Liu Y; Li F; Li W; Zhang Q; Gao Y; Zhang W; Zeng Z; Zeng R; Liao X; Zhao Q; Wan Z
BMC Geriatr; 2022 Apr; 22(1):321. PubMed ID: 35413794
[TBL] [Abstract][Full Text] [Related]
2. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.
Juraschek SP; Daya N; Appel LJ; Miller ER; Matsushita K; Michos ED; Windham BG; Ballantyne CM; Selvin E
J Am Geriatr Soc; 2019 Sep; 67(9):1795-1802. PubMed ID: 31493355
[TBL] [Abstract][Full Text] [Related]
3. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
[TBL] [Abstract][Full Text] [Related]
4. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
[TBL] [Abstract][Full Text] [Related]
5. Associations between inflammation, coagulation, cardiac strain and injury, and subclinical vascular disease with frailty in older men: a cross-sectional study.
McKechnie DGJ; Patel M; Papacosta AO; Lennon LT; Ellins EA; Halcox JPJ; Ramsay SE; Whincup PH; Wannamethee SG
BMC Geriatr; 2022 May; 22(1):405. PubMed ID: 35527242
[TBL] [Abstract][Full Text] [Related]
6. Subclinical Cardiovascular Disease in US Adults With and Without Diabetes.
Fang M; Wang D; Tang O; McEvoy JW; Echouffo-Tcheugui JB; Christenson RH; Selvin E
J Am Heart Assoc; 2023 Jun; 12(11):e029083. PubMed ID: 37254959
[TBL] [Abstract][Full Text] [Related]
7. 25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study.
Michos ED; Selvin E; Misialek JR; McEvoy JW; Ndumele CE; Folsom AR; Ballantyne CM; Lutsey PL
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821403
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study).
Puleo CW; Ayers CR; Garg S; Neeland IJ; Lewis AA; Pandey A; Drazner MH; de Lemos JA
Biomark Med; 2021 Nov; 15(16):1487-1498. PubMed ID: 34663078
[No Abstract] [Full Text] [Related]
9. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).
Madan N; Lee AK; Matsushita K; Hoogeveen RC; Ballantyne CM; Selvin E; McEvoy JW
Am J Cardiol; 2019 Jul; 124(2):245-252. PubMed ID: 31088661
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study.
Dadu RT; Fornage M; Virani SS; Nambi V; Hoogeveen RC; Boerwinkle E; Alonso A; Gottesman RF; Mosley TH; Ballantyne CM
Stroke; 2013 Jul; 44(7):1803-8. PubMed ID: 23660848
[TBL] [Abstract][Full Text] [Related]
11. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
Costacou T; Saenger AK; Orchard TJ
Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
Vergaro G; Gentile F; Aimo A; Januzzi JL; Richards AM; Lam CSP; de Boer RA; Meems LMG; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; Emdin M
ESC Heart Fail; 2022 Aug; 9(4):2084-2095. PubMed ID: 35510529
[TBL] [Abstract][Full Text] [Related]
13. Association between high-sensitivity cardiac troponin T and future cardiovascular incidence in a general Japanese population: results from the Tohoku medical megabank project.
Takahashi Y; Satoh M; Ohmomo H; Tanaka F; Osaki T; Tanno K; Nasu T; Sakata K; Morino Y; Sobue K; Sasaki M
Biomarkers; 2019 Sep; 24(6):566-573. PubMed ID: 30978115
[No Abstract] [Full Text] [Related]
14. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population.
Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T
Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215
[TBL] [Abstract][Full Text] [Related]
15. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
[TBL] [Abstract][Full Text] [Related]
16. Comparison of prognostic values of high-sensitivity cardiac troponin T and N-terminal prohormone brain natriuretic peptide to assess mortality in elderly inpatients.
Chen JR; Wang Q; Wu W; Zhang SJ
Clin Interv Aging; 2019; 14():81-90. PubMed ID: 30643397
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study.
Mathews L; Ishigami J; Ding N; Hoogeveen RC; Kucharska-Newton A; Ballantyne CM; Gottesman R; Selvin E; Matsushita K
J Am Heart Assoc; 2020 Mar; 9(5):e013560. PubMed ID: 32114886
[TBL] [Abstract][Full Text] [Related]
18. Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT.
Ascher SB; Scherzer R; de Lemos JA; Estrella MM; Jotwani VK; Garimella PS; Bullen AL; Ambrosius WT; Ballantyne CM; Nambi V; Killeen AA; Ix JH; Shlipak MG; Berry JD
J Am Heart Assoc; 2022 Mar; 11(6):e023314. PubMed ID: 35243872
[TBL] [Abstract][Full Text] [Related]
19. High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality--the CAVASIC Study.
Pohlhammer J; Kronenberg F; Rantner B; Stadler M; Peric S; Hammerer-Lercher A; Klein-Weigel P; Fraedrich G; Kollerits B
Atherosclerosis; 2014 Dec; 237(2):711-7. PubMed ID: 25463110
[TBL] [Abstract][Full Text] [Related]
20. High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change.
Pokharel Y; Mouhanna F; Schneider ALC; Rawlings AM; Knopman DS; Nambi V; Virani SS; Hoogeveen RC; Alonso A; Heiss G; Coresh J; Mosley T; Gottesman R; Selvin E; Ballantyne C; Power MC
J Am Geriatr Soc; 2019 Nov; 67(11):2353-2361. PubMed ID: 31359423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
